News from sanofi us A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( EuronextParis:SAN,NYSE:SNY)

Jun 30, 2015, 08:00 ET

New Film Documents Heart Felt Stories of People Living with High LDL Cholesterol

 Managing cholesterol is a private, emotional fight against a condition that cannot be seen or felt.1 Now, a new film highlights individuals...

Jun 09, 2015, 18:40 ET
Sanofi logo

FDA Advisory Committee Recommends Approval of Sanofi and Regeneron's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia

 Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the U.S....

Jun 08, 2015, 14:16 ET

Sanofi's Lyxumia® (lixisenatide) Demonstrated Cardiovascular Safety in People with Type 2 Diabetes and High CV Risk

 Sanofi announced today the presentation of full results of the Phase IIIb ELIXA study, which was designed to assess the cardiovascular (CV)...

Jun 06, 2015, 10:00 ET

Sanofi's Lyxumia® (lixisenatide) Statistically Superior to Rapid Acting Insulin for Body Weight Change with Similar Blood Sugar Control when Both are Added to Basal Insulin

 Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that Lyxumia® (lixisenatide) met all co-primary endpoints in a clinical trial...

Jun 04, 2015, 08:00 ET

Sanofi Announces Study Program Evaluating Toujeo® in a Real-Life Setting

Sanofi (EURONEXT: SAN and NYSE: SNY) announced today a program of Phase IV clinical trials to study Toujeo® (insulin glargine [rDNA origin]...

May 11, 2015, 08:38 ET

Singer and "Pretty Little Liars" Actress Lucy Hale Lends Her Voice to Voices of Meningitis™ to Help Improve Teen Booster Vaccination Rates

 Best known for her leading role on ABC Family's hit show "Pretty Little Liars," actress and singer Lucy Hale is lending her voice to the...

May 05, 2015, 09:00 ET

Majority of Canadians unprepared for an allergy emergency. Team Allerject educates to save lives

You're at a restaurant, and a guy at the next table is having a severe allergic reaction to something he ate. His lips are swollen, his face is...

May 01, 2015, 15:12 ET
http://www.multivu.com/players/English/7507551-sanofi-results-q1-2015/gallery/image/4e35adb9-7008-4627-a852-b1fce97d6f8e.HR.jpg

Sanofi Delivers Q1 2015 Business EPS Growth of 2.6% at CER and 12.8% on a Reported Basis

Sanofi (NYSE: SNY; EURONEXT: SAN) Q1 2015 Change (reported) Change (CER) Net sales €8,810...

Apr 30, 2015, 01:54 ET

Sanofi Résultats T1 2015 Interview du Directeur Financier Jérôme Contamine

Sanofi, un leader mondial et diversifié de la santé, publie ses résultats pour le premier trimestre 2015. Le Directeur Financier du...

Apr 30, 2015, 01:52 ET

Sanofi Q1 2015 Results - Interview With CFO Jérôme Contamine

Sanofi, a global and diversified healthcare leader, reports results for the first quarter of 2015. Jérôme Contamine, Chief Financial...

Mar 25, 2015, 12:15 ET
Sanofi Pasteur Announces FDA Approval of Quadracel DTaP-IPV Vaccine for Children 4 through 6 Years of Age

Sanofi Pasteur Announces FDA Approval of Quadracel DTaP-IPV Vaccine for Children 4 through 6 Years of Age

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration...

Mar 25, 2015, 08:00 ET

Skin Care Brand NeoStrata® Canada Joins Forces with Canadian activewear brand Lolë

NeoStrata to take part in the 2015 edition of the Lolë White Tour™ across Canada MONTREAL, March 25, 2015 /CNW Telbec/ - Canadian...

Mar 19, 2015, 07:00 ET

Sanofi Announces Top-Line Results for Cardiovascular Outcomes Study of Lyxumia® (lixisenatide)

 Sanofi announced today top-line results of the Phase IIIb ELIXA cardiovascular outcomes study, which compared lixisenatide to placebo in a...

Mar 15, 2015, 11:00 ET
Sanofi logo

Sanofi and Regeneron Announce 18-Month Results of ODYSSEY LONG TERM Trial with Praluent™ (alirocumab) Published in The New England Journal of Medicine

 Sanofi and Regeneron Pharmaceuticals, Inc. today announced that 18-month (78-week) results of a Phase 3 trial of Praluent™ (alirocumab),...

Feb 25, 2015, 20:25 ET

Sanofi Receives FDA Approval of Once-Daily Basal Insulin Toujeo®

 Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Toujeo® (insulin glargine [rDNA origin] injection, 300...

Feb 05, 2015, 07:49 ET
Sanofi Delivers Business EPS Growth of 7.3% at CER in 2014

Sanofi Delivers Business EPS Growth of 7.3% at CER in 2014

 Sanofi (NYSE: SNY; EURONEXT: SAN) Q4 2014 Change (reported) Change (CER) 2014 Change (reported) Change (CER) Net...

Feb 05, 2015, 02:16 ET

Sanofi - Résultats 2014 - Interview du Président du Conseil d'administration & DG Serge Weinberg

Sanofi, un leader mondial et diversifié de la santé, publie ses résultats pour l'année 2014. Le Président du Conseil...

Feb 05, 2015, 02:14 ET

Sanofi FY 2014 - Interview With Chairman & CEO Serge Weinberg

Sanofi, a global and diversified healthcare leader, reports annual results for 2014. Chairman of the Board of Directors and CEO Serge Weinberg...

Feb 03, 2015, 07:00 ET
Afrezza(R) Inhaler with 8 unit and 4 unit cartridges of Afrezza (insulin human) Inhalation Powder.

Sanofi and MannKind Announce Afrezza®, the Only Inhaled Insulin, Now Available in the U.S.

 Sanofi and MannKind Corporation announced today that Afrezza® (insulin human) Inhalation Powder, the only inhaled insulin, is now...

Dec 12, 2014, 08:00 ET

Sanofi Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent (Influenza Vaccine) for Adults

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration...